Form D Explorer

Source evidence

NSG BioInnovation Fund, L.P. · 0002134809-26-000001

D filed May 19, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
UGLAND HOUSE
street1
C/O MAPLES CORPORATE SERVICES LIMITED
street2
#309
zipCode
KY1-1104
entityName
NSG BioInnovation Fund, L.P.
entityType
Limited Partnership
stateOrCountry
E9
jurisdictionOfInc
CAYMAN ISLANDS
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold0number0/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amountIndefiniteindefiniteUnavailable/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count0number0/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 5beb06fafad989115700007d099a029bb8f3c1632837cc26f7b6eebdada587b4. This proves extraction identity, not the accuracy of the filer's claims.